title: FDA announces reforms of drug review process.
authors.forename: C
authors.initials: C
authors.lastname: Anderson
mesh_terms: D016265:Conflict of Interest; D004341:Drug Evaluation / Q000379:methods*; D004345:Drug Industry; D014481:United States; D014486:United States Food and Drug Administration